Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Assets (2016 - 2025)

Organogenesis Holdings has reported Non-Current Assets over the past 10 years, most recently at $236.5 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $236.5 million for Q4 2025, up 11.61% from a year ago — trailing twelve months through Dec 2025 was $846.8 million (down 1.54% YoY), and the annual figure for FY2025 was $236.5 million, up 11.61%.
  • Non-Current Assets for Q4 2025 was $236.5 million at Organogenesis Holdings, up from $210.1 million in the prior quarter.
  • Over the last five years, Non-Current Assets for ORGO hit a ceiling of $237.1 million in Q3 2023 and a floor of $133.9 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $217.4 million (2021), compared with a mean of $210.1 million.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 86.65% in 2021 and later fell 13.87% in 2025.
  • Organogenesis Holdings' Non-Current Assets stood at $216.3 million in 2021, then increased by 4.84% to $226.8 million in 2022, then grew by 3.63% to $235.0 million in 2023, then dropped by 9.8% to $211.9 million in 2024, then rose by 11.61% to $236.5 million in 2025.
  • The last three reported values for Non-Current Assets were $236.5 million (Q4 2025), $210.1 million (Q3 2025), and $200.9 million (Q2 2025) per Business Quant data.